Since miR-1246 was expressed higher in ER- breast cancer subtypes and induced pro-inflammatory responses in MSCs by targeting PRKAR1A and PPP2CB, we hypothesized potential roles of PRKAR1A and PPP2CB as tumor-suppressors in breast cancer. This evidence concerns the gene PRKAR1A and neoplasm.